The biological function of m6A reader YTHDF2 and its role in human disease
- PMID: 33593354
- PMCID: PMC7885220
- DOI: 10.1186/s12935-021-01807-0
The biological function of m6A reader YTHDF2 and its role in human disease
Abstract
N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional modification and the most prevalent internal RNA modification in eukaryotic cells. YT521-B homology domain family 2 (YTHDF2) is a member of m6A "readers" and its role in human diseases remains unclear. Accumulating evidence suggests that YTHDF2 is greatly implicated in many aspects of human cancers and non-cancers through various mechanisms. YTHDF2 takes a great part in multiple biological processes, such as migration, invasion, metastasis, proliferation, apoptosis, cell cycle, cell viability, cell adhesion, differentiation and inflammation, in both human cancers and non-cancers. Additionally, YTHDF2 influences various aspects of RNA metabolism, including mRNA decay and pre-ribosomal RNA (pre-rRNA) processing. Moreover, emerging researches indicate that YTHDF2 predicts the prognosis of different cancers. Herein, we focus on concluding YTHDF2-associated mechanisms and potential biological functions in kinds of cancers and non-cancers, and its prospects as a prognostic biomarker.
Keywords: Biological function; Cancers; Non-cancers; Up and downregulation; YTHDF2; m6A; signaling pathways.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
m6A binding protein YTHDF2 in cancer.Exp Hematol Oncol. 2022 Apr 5;11(1):21. doi: 10.1186/s40164-022-00269-y. Exp Hematol Oncol. 2022. PMID: 35382893 Free PMC article. Review.
-
YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.Cancer Sci. 2023 Nov;114(11):4299-4313. doi: 10.1111/cas.15953. Epub 2023 Sep 12. Cancer Sci. 2023. PMID: 37700438 Free PMC article.
-
Decreased ALKBH5, FTO, and YTHDF2 in Peripheral Blood Are as Risk Factors for Rheumatoid Arthritis.Biomed Res Int. 2020 Aug 20;2020:5735279. doi: 10.1155/2020/5735279. eCollection 2020. Biomed Res Int. 2020. PMID: 32884942 Free PMC article. Clinical Trial.
-
Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker.Front Cell Dev Biol. 2022 Aug 31;10:954214. doi: 10.3389/fcell.2022.954214. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36120577 Free PMC article.
-
Biological functions of the m6A reader YTHDF2 and its role in central nervous system disorders.Biochem Pharmacol. 2024 Dec;230(Pt 1):116576. doi: 10.1016/j.bcp.2024.116576. Epub 2024 Oct 16. Biochem Pharmacol. 2024. PMID: 39424201 Review.
Cited by
-
PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to control cancer cell radiosensitivity.Mol Ther. 2023 Sep 6;31(9):2633-2650. doi: 10.1016/j.ymthe.2023.07.018. Epub 2023 Jul 23. Mol Ther. 2023. PMID: 37482682 Free PMC article.
-
Upregulation of UBR1 m6A Methylation by METTL14 Inhibits Autophagy in Spinal Cord Injury.eNeuro. 2023 Jun 2;10(6):ENEURO.0338-22.2023. doi: 10.1523/ENEURO.0338-22.2023. Print 2023 Jun. eNeuro. 2023. PMID: 37094938 Free PMC article.
-
FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway.J Clin Transl Hepatol. 2025 May 28;13(5):385-394. doi: 10.14218/JCTH.2025.00007. Epub 2025 Apr 18. J Clin Transl Hepatol. 2025. PMID: 40385944 Free PMC article.
-
Enriched environment inhibits GLT-1 ubiquitination by downregulating SMURF1 to attenuate ischemic brain injury induced excitotoxicity.Cell Biosci. 2025 Aug 28;15(1):124. doi: 10.1186/s13578-025-01457-z. Cell Biosci. 2025. PMID: 40877964 Free PMC article.
-
Diagnostic value and immune infiltration characterization of YTHDF2 as a critical m6A regulator in osteoarthritic synovitis.J Orthop Surg Res. 2023 Jul 27;18(1):535. doi: 10.1186/s13018-023-03933-z. J Orthop Surg Res. 2023. PMID: 37496062 Free PMC article.
References
-
- Maity, A. and B. Das, N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. 2016. 283(9): p. 1607–30. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources